Search research articles
Contact Us
Filters
Showing results (141-150 of 214) with videos related to
Page
of 22
Sort By:
Cancer
|
January 12, 2019
Impact of tumor, treatment, and access on outcomes in bladder cancer: Can equal access overcome race-based differences in survival?
Alexander P Cole, Sean A Fletcher, Sebastian Berg, et al.
Advances in Radiation Oncology
|
November 4, 2020
Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19
Nicholas G Zaorsky, James B Yu, Sean M McBride, et al.
Clinical Genitourinary Cancer
|
December 3, 2017
Pathologic Outcomes of Gleason 6 Favorable Intermediate-Risk Prostate Cancer Treated With Radical Prostatectomy: Implications for Active Surveillance
David D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
Cancer
|
May 19, 2025
Disparities in receipt of palliative-intent treatment among disaggregated Hispanic populations with breast, lung, and prostate cancer in the United States
Shriya K Garg, Khushi Kohli, Isha K Garg, et al.
Cancer
|
August 24, 2017
Receipt of definitive therapy in elderly patients with unfavorable-risk prostate cancer
David D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
The Journal of Urology
|
November 12, 2018
Quality of Care in the Treatment of Localized Intermediate and High Risk Prostate Cancer at Minority Serving Hospitals
Marieke J Krimphove, Sean A Fletcher, Alexander P Cole, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 19, 2018
The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors
Luke R G Pike, Andrew Bang, Brandon A Mahal, et al.
Urologic Oncology
|
May 21, 2015
Differential post-prostatectomy cancer-specific survival of occult T3 vs. clinical T3 prostate cancer: Implications for managing patients upstaged on prostate magnetic resonance imaging
Vinayak Muralidhar, Kathryn T Dinh, Brandon A Mahal, et al.
JCO Oncology Practice
|
November 18, 2022
Shorter Radiation Regimens and Treatment Noncompletion Among Patients With Breast and Prostate Cancer in the United States: An Analysis of Racial Disparities in Access and Quality
Edward Christopher Dee, Neil K Taunk, Fumiko L Chino, et al.
European Urology
|
December 18, 2018
Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate Cancer
David D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
Page
of 22
Search research articles
Search
Showing results (141-150 of 214) with videos related to
Sort By:
Page
of 22
Cancer
|
January 12, 2019
Impact of tumor, treatment, and access on outcomes in bladder cancer: Can equal access overcome race-based differences in survival?
Alexander P Cole, Sean A Fletcher, Sebastian Berg, et al.
Advances in Radiation Oncology
|
November 4, 2020
Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19
Nicholas G Zaorsky, James B Yu, Sean M McBride, et al.
Clinical Genitourinary Cancer
|
December 3, 2017
Pathologic Outcomes of Gleason 6 Favorable Intermediate-Risk Prostate Cancer Treated With Radical Prostatectomy: Implications for Active Surveillance
David D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
Cancer
|
May 19, 2025
Disparities in receipt of palliative-intent treatment among disaggregated Hispanic populations with breast, lung, and prostate cancer in the United States
Shriya K Garg, Khushi Kohli, Isha K Garg, et al.
Cancer
|
August 24, 2017
Receipt of definitive therapy in elderly patients with unfavorable-risk prostate cancer
David D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
The Journal of Urology
|
November 12, 2018
Quality of Care in the Treatment of Localized Intermediate and High Risk Prostate Cancer at Minority Serving Hospitals
Marieke J Krimphove, Sean A Fletcher, Alexander P Cole, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 19, 2018
The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors
Luke R G Pike, Andrew Bang, Brandon A Mahal, et al.
Urologic Oncology
|
May 21, 2015
Differential post-prostatectomy cancer-specific survival of occult T3 vs. clinical T3 prostate cancer: Implications for managing patients upstaged on prostate magnetic resonance imaging
Vinayak Muralidhar, Kathryn T Dinh, Brandon A Mahal, et al.
JCO Oncology Practice
|
November 18, 2022
Shorter Radiation Regimens and Treatment Noncompletion Among Patients With Breast and Prostate Cancer in the United States: An Analysis of Racial Disparities in Access and Quality
Edward Christopher Dee, Neil K Taunk, Fumiko L Chino, et al.
European Urology
|
December 18, 2018
Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate Cancer
David D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
Page
of 22